Catalyst Wire Dossier Catalyst Wire Dossier

INCB019602

INCB019602 · Incyte Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCB019602, covering 2012-10-30 to 2012-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes [Phase 2]

See pricing